The Newsroom
Find out the latest about Calidi. Announcements, press coverage, publications, and company info—it’s all here.
Press Release
Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences
Calidi Biotherapeutics, Inc. will present data on RTNova, its systemic antitumor virotherapy platform, at several upcoming scientific conferences, including the International Oncolytic Virotherapy Conference in Rotterdam and Immuno US 2024 in San Diego. RTNova offers a novel approach to treating previously untreatable metastatic cancers by targeting multiple tumor sites and altering the tumor immune microenvironment. Dr. Antonio F. Santidrian and Dr. Duong H. Nguyen will lead these presentations, which have been crucial in advancing this innovative therapy.
Press Release
event
RTNova
NeuroNova
Supernova
RTNova
Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences
October 24, 2024
Discover More
Discover More
Discover More
Press Release
event
NeuroNova
Supernova
RTNova
Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement
October 23, 2024
Discover More
Discover More
Discover More
Press Release
event
NeuroNova
Supernova
RTNova
Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma
September 30, 2024
Discover More
Discover More
Discover More
Press Release
event
NeuroNova
Supernova
RTNova
Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results
August 13, 2024
Discover More
Discover More
Discover More
Press Release
event
NeuroNova
Supernova
RTNova
Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor
July 29, 2024
Discover More
Discover More
Discover More
Press Release
event
SuperNova (SNV)
NeuroNova
Supernova
RTNova
Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform
July 18, 2024
Discover More
Discover More
Discover More
Press Release
Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences
October 24, 2024
Discover More
Press Release
Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement
October 23, 2024
Discover More
Press Release
Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma
September 30, 2024
Discover More
Press Release
Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results
August 13, 2024
Discover More
Press Release
Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor
July 29, 2024
Discover More
Press Release
Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform
July 18, 2024
Discover More
Publication
event
RTNova
RTNova
NeuroNova
Supernova
Transforming Tumor Immune Microenvironments with a Novel Systemic Enveloped Oncolytic Virotherapy Targeting All Tumor Sites
June 1, 2024
Discover More
Discover More
Publication
event
SuperNova (SNV)
SuperNova (SNV)
NeuroNova
Supernova
Non-Clinical Evidence Supporting the Upcoming CLD-201 Clinical Trial: Cell-Based Oncolytic Virotherapy for Multiple Solid Tumors
June 1, 2024
Discover More
Discover More
Publication
event
NeuroNova (NNV)
NeuroNova (NNV)
NeuroNova
Supernova
Phase 1 Study of Multiple Intracerebral Doses of a Neural Stem Cell-based Oncolytic Virotherapy for Treatment of Recurrent High-grade Gliomas
June 1, 2024
Discover More
Discover More
Publication
event
NeuroNova & SuperNova
NeuroNova & SuperNova
NeuroNova
Supernova
Stem Cell Platforms for Enhanced Oncolytic Virotherapy
April 16, 2024
Discover More
Discover More
Publication
event
NeuroNova & SuperNova
NeuroNova & SuperNova
NeuroNova
Supernova
Deciphering Anticancer Mechanisms of Oncolytic Virus-loaded Stem Cells
April 9, 2024
Discover More
Discover More
Publication
event
SuperNova (SNV)
SuperNova (SNV)
NeuroNova
Supernova
Annual Meeting – SITC 2023 – Nov 1st to 5th 2023 in San Diego, CA, USA.
November 3, 2023
Discover More
Discover More
Media
Good Morning San Diego, Calidi Bio Treatments Discussed
April 13, 2019
Discover More
Media
KUSI San Diego News - Calidi Bio CEO, Allan Camaisa Interviewed
April 12, 2019
Discover More
In The News
Calidi Biotherapeutics: A Promising Player in the Cancer Treatment Market
October 9, 2023
Discover More
Discover More
In The News
Analyst Bullish On Calidi Biotherapeutics, Newly Listed Cancer Treatment Player
October 9, 2023
Discover More
Discover More